SCENESSE® applied under five-year Veterans Affairs contract 2023 Announcements . Corporate 26.07.2023
CLINUVEL secures IP for melanocortins to treat central nervous system disorders 2023 Announcements . Corporate 14.07.2023
Technical Note: Developing a melanocortin pipeline 2023 Announcements . Corporate . Regulatory 27.01.2023